KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Discontinued OperationsCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Shares Issued (2016 - 2023)

TherapeuticsMD's Shares Issued history spans 11 years, with the latest figure at $2.0 million for Q4 2023.

  • For Q4 2023, Shares Issued changed N/A year-over-year to $2.0 million; the TTM value through Dec 2023 reached $3.2 million, down 98.24%, while the annual FY2023 figure was $3.2 million, 28.4% up from the prior year.
  • Shares Issued reached $2.0 million in Q4 2023 per TXMD's latest filing, up from -$1000.0 in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $151.0 million in Q2 2021 to a low of -$1000.0 in Q3 2023.
  • Average Shares Issued over 4 years is $22.0 million, with a median of $103053.5 recorded in 2019.
  • Peak YoY movement for Shares Issued: crashed 99.99% in 2019, then surged 160551.06% in 2021.
  • A 4-year view of Shares Issued shows it stood at $76.9 million in 2019, then crashed by 99.86% to $106000.0 in 2020, then soared by 1064.15% to $1.2 million in 2021, then surged by 62.24% to $2.0 million in 2023.
  • Per Business Quant, the three most recent readings for TXMD's Shares Issued are $2.0 million (Q4 2023), -$1000.0 (Q3 2023), and $1.2 million (Q4 2021).